Skip to main content
Learn more

Analysis of Circulating Tumor DNA for Early Relapse Detection in Stage III Colorectal Cancer ESMO 2020

Circulating tumor DNA (ctDNA) has emerged as a promising biomarker for early prediction of relapse across different tumor types.

Download PDF